Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;50(10):3000605221132882.
doi: 10.1177/03000605221132882.

Diagnosis and treatment of acquired factor VIII deficiency: a case report and literature review

Affiliations
Review

Diagnosis and treatment of acquired factor VIII deficiency: a case report and literature review

Yingli Ren et al. J Int Med Res. 2022 Oct.

Abstract

Acquired haemophilia A (AHA) is a rare haemorrhagic disease characterized by spontaneous extensive subcutaneous haemorrhage and soft tissue haematoma. The activated partial thromboplastin time is significantly prolonged and cannot be corrected by normal plasma. Approximately 50% of AHA patients lack a specific aetiology, so this can easily result in a misdiagnosis. This current case report describes a 27-year-old male that presented with gingival bleeding, haematuria and haematochezia with no obvious cause. At first, it was thought that he might have experienced anticoagulant rodenticide poisoning, but the subsequent anticoagulant rodenticide test was negative. At the same time, the patient was screened for mutations associated with bleeding and coagulation diseases. Two mutations were identified: a p.Y471H mutation the plasminogen activator, tissue type (PLAT) gene; and a p.Y244Y mutation the serpin family E member 1 (SERPINE1) gene. It should be noted that patient had no previous history of thrombosis or haemorrhagic disease, which confused the diagnosis. A professional haemophilia research centre provided clarification of the diagnosis when anti-factor VIII antibodies were detected. The patient was treated with 30 mg/day prednisone orally. Multiple follow-up examinations showed continuous complete remission. No factor VIII antibodies were detected in his blood and coagulation factor VIII increased significantly.

Keywords: Bleeding disorders; acquired haemophilia A; anti-coagulation factor VIII antibody; coagulation factors; factor VIII.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1.
Figure 1.
An initial physical examination of a 27-year-old male that presented with gingival bleeding, haematuria and haematochezia with no obvious cause showed that the leg circumference of the left thigh was greater than that of the right thigh.
Figure 2.
Figure 2.
Computed tomography imaging of the lungs and abdomen of a 27-year-old male that presented with gingival bleeding, haematuria and haematochezia with no obvious cause showed double lung inflammation with bilateral pleural effusion and adjacent lung tissue insufflation (a); abdominal and pelvic effusion, thick peritoneum and omentum, and abdominal and pelvic wall oedema (b); bilateral femoral muscle space and subcutaneous fat and soft tissue oedema (obvious on the left) (c).
Figure 3.
Figure 3.
A physical examination of a 27-year-old male that presented with gingival bleeding, haematuria and haematochezia with no obvious cause showed large areas of ecchymosis on the trunk, arms and tops of the thighs. The colour version of this figure is available at: http://imr.sagepub.com.
Figure 4.
Figure 4.
Computed tomography imaging of the hip joints of a 27-year-old male that presented with gingival bleeding, haematuria and haematochezia with no obvious cause showed swelling of the left iliopsoas muscle, so bleeding could not be excluded.
Figure 5.
Figure 5.
Treatment of acquired coagulation factor VIII (FVIII) deficiency.

References

    1. Shetty S, Bhave M, Ghosh K. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev 2011; 10: 311–316. - PubMed
    1. Moccia F, Tognoni E, Boccaccio P. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy. Ann Ital Med Int 2000; 15: 172–176. - PubMed
    1. Gebbink MF. Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. J Thromb Haemost 2011; 9: 174–181. - PubMed
    1. Heiman M, Gupta S, Khan SS, et al.. Complete Plasminogen Activator Inhibitor 1 Deficiency. 2017. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK447152/. - PubMed
    1. Gagnier JJ, Kienle G, Altman DG, et al.. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache 2013; 53: 1541–1547. - PubMed

Supplementary concepts